416 related articles for article (PubMed ID: 34058750)
1. Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV.
Zheng W; Wu H; Wang T; Zhan S; Liu X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34058750
[TBL] [Abstract][Full Text] [Related]
2. Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.
Zheng W; Wu H; Liu C; Yan Q; Wang T; Wu P; Liu X; Jiang Y; Zhan S
Front Immunol; 2021; 12():707287. PubMed ID: 34394108
[TBL] [Abstract][Full Text] [Related]
3. Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.
Wang M; Fu D; Yao L; Li J
Comb Chem High Throughput Screen; 2021; 24(2):294-305. PubMed ID: 32767929
[TBL] [Abstract][Full Text] [Related]
4. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
5. Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin.
Li Y; Yu S; Li Y; Liang X; Su M; Li R
Front Endocrinol (Lausanne); 2021; 12():714909. PubMed ID: 34712201
[TBL] [Abstract][Full Text] [Related]
6. Dual action effects of ethyl-p-methoxycinnamate against dengue virus infection and inflammation via NF-κB pathway suppression.
Tarasuk M; Songprakhon P; Muhamad P; Panya A; Sattayawat P; Yenchitsomanus PT
Sci Rep; 2024 Apr; 14(1):9322. PubMed ID: 38654034
[TBL] [Abstract][Full Text] [Related]
7. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
8. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
9. Co-Infection between Dengue Virus and SARS-CoV-2 in Cali, Colombia.
Agudelo-Rojas OL; Rebellón-Sánchez DE; Llanos Torres J; Zapata-Vásquez IL; Rodríguez S; Robles-Castillo S; Tejada Vega A; Parra-Lara LG; Rosso F
Am J Trop Med Hyg; 2023 Sep; 109(3):536-541. PubMed ID: 37580025
[TBL] [Abstract][Full Text] [Related]
10. Presentation of fatal stroke due to SARS-CoV-2 and dengue virus coinfection.
Estofolete CF; Machado LF; Zini N; Luckemeyer GD; Moraes MM; Dos Santos TMIL; Dos Santos BF; Ruiz LGP; Vasilakis N; Lobo SMA; Nogueira ML
J Med Virol; 2021 Mar; 93(3):1770-1775. PubMed ID: 32881018
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs.
Hasan MZ; Islam S; Matsumoto K; Kawai T
Sci Rep; 2021 Aug; 11(1):16814. PubMed ID: 34413339
[TBL] [Abstract][Full Text] [Related]
12. Alpha-mangostin inhibits viral replication and suppresses nuclear factor kappa B (NF-κB)-mediated inflammation in dengue virus infection.
Tarasuk M; Songprakhon P; Chieochansin T; Choomee K; Na-Bangchang K; Yenchitsomanus PT
Sci Rep; 2022 Sep; 12(1):16088. PubMed ID: 36168031
[TBL] [Abstract][Full Text] [Related]
13. Dengue-COVID-19 coinfection: the first reported case in the Philippines.
Saipen A; Demot B; De Leon L
Western Pac Surveill Response J; 2021; 12(1):35-39. PubMed ID: 34094622
[TBL] [Abstract][Full Text] [Related]
14. Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge.
Bicudo N; Bicudo E; Costa JD; Castro JALP; Barra GB
Braz J Infect Dis; 2020; 24(5):452-454. PubMed ID: 32866435
[TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus Co-infection: Indian Perspectives.
Venkatesh U; Ish P; Kumari S; Gupta N; Sharma A
Disaster Med Public Health Prep; 2022 Oct; 16(5):1769-1771. PubMed ID: 34344496
[TBL] [Abstract][Full Text] [Related]
16. Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study.
Gu YY; Zhang M; Cen H; Wu YF; Lu Z; Lu F; Liu XS; Lan HY
PLoS One; 2021; 16(1):e0245209. PubMed ID: 33444408
[TBL] [Abstract][Full Text] [Related]
17. Uncovering the genetic links of SARS-CoV-2 infections on heart failure co-morbidity by a systems biology approach.
Zhang G; Cui X; Zhang L; Liu G; Zhu X; Shangguan J; Zhang W; Zheng Y; Zhang H; Tang J; Zhang J
ESC Heart Fail; 2022 Oct; 9(5):2937-2954. PubMed ID: 35727093
[TBL] [Abstract][Full Text] [Related]
18. Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets.
Li R; Li Y; Liang X; Yang L; Su M; Lai KP
Brief Bioinform; 2021 Mar; 22(2):1279-1290. PubMed ID: 33169132
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management.
Prapty CNBS; Rahmat R; Araf Y; Shounak SK; Noor-A-Afrin ; Rahaman TI; Hosen MJ; Zheng C; Hossain MG
Rev Med Virol; 2023 Jan; 33(1):e2340. PubMed ID: 35238422
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
